| 2022 | An In-Silico Identification of Potential Flavonoids against Kidney Fibrosis Targeting TGF beta R-1 | 권영주 | Article |
| 2002 | Determination of a new isoquinolinedione derivative, 7-anilino-5,8-isoquinolinedione, in plasma, urine and tissue homogenates by high-performance liquid chromatography | 유충규 | Article; Proceedings Paper |
| 2021 | Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents | 이화정; 이재옥 | Article |
| 2020 | Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects | 곽혜선 | Article |
| 2019 | Effects of Piperazine Derivative on Paclitaxel Pharmacokinetics | 박혜영; 이화정; 이정연 | Article |
| 2021 | Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers | 곽혜선; 송곤진 | Article |
| 2000 | Enantioselective determination of cetirizine in human urine by HPLC | 박혜영 | Article |
| 2021 | Influence of C Upsilon P2C9 Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis | 곽혜선 | Review |
| 2018 | Intestinal P-glycoprotein inhibitors, benzoxanthone analogues | 이화정; 권영주; 이재옥 | Article |
| 2019 | Pharmacokinetic Alteration of Paclitaxel by Ferulic Acid Derivative | 박혜영; 이화정; 이정연; 이재옥 | Article |
| 2020 | Vancomycin pharmacokinetics in critically ill neonates receiving extracorporeal membrane oxygenation | 곽혜선; 이은미 | Article |
